Dopamine and glucose, obesity, and reward deficiency syndrome

K Blum, PK Thanos, MS Gold - Frontiers in psychology, 2014 - frontiersin.org
Obesity as a result of overeating as well as a number of well described eating disorders has
been accurately considered to be a world-wide epidemic. Recently a number of theories …

Molecular imaging of opioid and dopamine systems: insights into the pharmacogenetics of opioid use disorders

JA Burns, DS Kroll, DE Feldman, C Kure Liu… - Frontiers in …, 2019 - frontiersin.org
Opioid use in the United States has steadily risen since the 1990s, along with staggering
increases in addiction and overdose fatalities. With this surge in prescription and illicit opioid …

Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution

A Doehring, N von Hentig, J Graff… - Pharmacogenetics …, 2009 - journals.lww.com
Aim Addictive behavior is importantly mediated by mesolimbic dopaminergic signaling.
Here, we comprehensively analyzed the DRD2 gene locus, and in addition, the ANKK1 …

[HTML][HTML] Reviewing pharmacogenetics to advance precision medicine for opioids

L Magarbeh, I Gorbovskaya, B Le Foll, R Jhirad… - Biomedicine & …, 2021 - Elsevier
Background Adequate opioid prescribing is critical for therapeutic success of pain
management. Despite the widespread use of opioids, optimized opioid therapy remains …

Impact of Genetic Polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 Genes on Methadone Therapy in Han Chinese Patients

CC Hung, MH Chiou, BH Huang, YW Hsieh… - …, 2011 - Taylor & Francis
Aim: The present study explored the integrative effect of genes encoding methadone
pharmacokinetic and pharmacodynamic pathways on methadone maintenance doses in …

Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity …

K Blum, M Febo, T McLaughlin, FJ Cronje… - Journal of Behavioral …, 2014 - akjournals.com
Background Following the first association between the dopamine D2 receptor gene
polymorphism and severe alcoholism, there has been an explosion of research reports in …

Association between polymorphisms of DRD2 and DRD4 and opioid dependence: Evidence from the current studies

D Chen, F Liu, Q Shang, X Song… - American Journal of …, 2011 - Wiley Online Library
Several studies have assessed the association between genetic polymorphisms of DRD2
and DRD4 genes and opioid dependence risk, while the results were inconsistent. We …

Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment

S Crettol, J Besson, M Croquette-Krokar… - Progress in Neuro …, 2008 - Elsevier
BACKGROUND: Genetic variations of the dopamine and opioid receptors could influence
the response to methadone maintenance treatment (MMT). METHODS: We included 238 …

Pharmacogenetics of opioid use disorder treatment

RC Crist, TK Clarke, WH Berrettini - CNS drugs, 2018 - Springer
Opioid use disorder (OUD) is a significant health problem in the United States and many
other countries. A combination of issues, most notably increased prescription of opioid …

ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure

EC Nelson, MT Lynskey, AC Heath, N Wray… - JAMA …, 2013 - jamanetwork.com
Context The genetic contribution to liability for opioid dependence is well established;
identification of the responsible genes has proved challenging. Objective To examine …